Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceuticals
100.0
%
| 27 | 100.0 % | 29 | 100.0 % | +6.12% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
60.0
%
| 16 | 60.0 % | 17 | 60.0 % | +6.12% |
United States
40.0
%
| 11 | 40.0 % | 11 | 40.0 % | +6.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 25/03/19 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 14/08/22 |
James Bowen
IRC | Investor Relations Contact | - | - |
Emilio Presti
SAM | Sales & Marketing | - | - |
Diane Gajewczyk
PRN | Corporate Officer/Principal | - | 04/06/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 07/08/16 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 20/06/23 |
Craig Mull
CEO | Chief Executive Officer | - | 25/03/19 |
Hubert Walinski
BRD | Director/Board Member | - | 20/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,107,316 | 13,265,519 ( 55.03 %) | 0 | 55.03 % |
Company contact information
Cipher Pharmaceuticals, Inc.
5750 Explorer Drive Suite 404
L4W 0A9, Mississauga
+905-602-5840
http://www.cipherpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |